Ockenhouse CF - Search Results

1

Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.

Porter MD, Nicki J, Pool CD, DeBot M, Illam RM, Brando C, Bozick B, De La Vega P, Angra D, Spaccapelo R, Crisanti A, Murphy JR, Bennett JW, Schwenk RJ, Ockenhouse CF, Dutta S. Porter MD, et al. Among authors: ockenhouse cf. Clin Vaccine Immunol. 2013 Jun;20(6):803-10. doi: 10.1128/CVI.00066-13. Epub 2013 Mar 27. Clin Vaccine Immunol. 2013. PMID: 23536694 Free PMC article.

2

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G, Holland C, Dowler M, Cohen J, Ballou WR. Stoute JA, et al. Among authors: ockenhouse cf. J Infect Dis. 1998 Oct;178(4):1139-44. doi: 10.1086/515657. J Infect Dis. 1998. PMID: 9806046 Clinical Trial.

3

Expression, purification and characterization of a functional region of the Plasmodium vivax Duffy binding protein.

Dutta S, Daugherty JR, Ware LA, Lanar DE, Ockenhouse CF. Dutta S, et al. Among authors: ockenhouse cf. Mol Biochem Parasitol. 2000 Jul;109(2):179-84. doi: 10.1016/s0166-6851(00)00244-9. Mol Biochem Parasitol. 2000. PMID: 10960177 No abstract available.

4

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group. Kester KE, et al. Among authors: ockenhouse cf. J Infect Dis. 2001 Feb 15;183(4):640-7. doi: 10.1086/318534. Epub 2001 Jan 24. J Infect Dis. 2001. PMID: 11170991 Clinical Trial.

5

Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A.

Ockenhouse CF, Barbosa A, Blackall DP, Murphy CI, Kashala O, Dutta S, Lanar DE, Daugherty JR. Ockenhouse CF, et al. Mol Biochem Parasitol. 2001 Mar;113(1):9-21. doi: 10.1016/s0166-6851(00)00375-3. Mol Biochem Parasitol. 2001. PMID: 11254950

6

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

Uthaipibull C, Aufiero B, Syed SE, Hansen B, Guevara Patiño JA, Angov E, Ling IT, Fegeding K, Morgan WD, Ockenhouse C, Birdsall B, Feeney J, Lyon JA, Holder AA. Uthaipibull C, et al. J Mol Biol. 2001 Apr 13;307(5):1381-94. doi: 10.1006/jmbi.2001.4574. J Mol Biol. 2001. PMID: 11292349

7

Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.

Dutta S, Ware LA, Barbosa A, Ockenhouse CF, Lanar DE. Dutta S, et al. Among authors: ockenhouse cf. Infect Immun. 2001 Sep;69(9):5464-70. doi: 10.1128/IAI.69.9.5464-5470.2001. Infect Immun. 2001. PMID: 11500418 Free PMC article.

8

Identification, expression, and functional characterization of MAEBL, a sporozoite and asexual blood stage chimeric erythrocyte-binding protein of Plasmodium falciparum.

Ghai M, Dutta S, Hall T, Freilich D, Ockenhouse CF. Ghai M, et al. Among authors: ockenhouse cf. Mol Biochem Parasitol. 2002 Aug 7;123(1):35-45. doi: 10.1016/s0166-6851(02)00123-8. Mol Biochem Parasitol. 2002. PMID: 12165387

9

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.

Angov E, Aufiero BM, Turgeon AM, Van Handenhove M, Ockenhouse CF, Kester KE, Walsh DS, McBride JS, Dubois MC, Cohen J, Haynes JD, Eckels KH, Heppner DG, Ballou WR, Diggs CL, Lyon JA. Angov E, et al. Among authors: ockenhouse cf. Mol Biochem Parasitol. 2003 May;128(2):195-204. doi: 10.1016/s0166-6851(03)00077-x. Mol Biochem Parasitol. 2003. PMID: 12742586

10

Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems.

Yadava A, Ockenhouse CF. Yadava A, et al. Among authors: ockenhouse cf. Infect Immun. 2003 Sep;71(9):4961-9. doi: 10.1128/IAI.71.9.4961-4969.2003. Infect Immun. 2003. PMID: 12933838 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page